Sleep Apnea - Pipeline Review, H1 2015

Published: Jan, 2015 | Pages: 51 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Sleep Apnea - Pipeline Review, H1 2015

Summary

Global Markets Direct's, 'Sleep Apnea - Pipeline Review, H1 2015', provides an overview of the Sleep Apnea's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Sleep Apnea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Sleep Apnea and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Sleep Apnea
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities 
- The report reviews key players involved in the therapeutics development for Sleep Apnea and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects 
- A review of the Sleep Apnea products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Sleep Apnea pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Sleep Apnea
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Sleep Apnea pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Sleep Apnea Overview 6
Therapeutics Development 7
Pipeline Products for Sleep Apnea - Overview 7
Pipeline Products for Sleep Apnea - Comparative Analysis 8
Sleep Apnea - Therapeutics under Development by Companies 9
Sleep Apnea - Pipeline Products Glance 10
Clinical Stage Products 10
Early Stage Products 11
Sleep Apnea - Products under Development by Companies 12
Sleep Apnea - Companies Involved in Therapeutics Development 13
Cortex Pharmaceuticals, Inc. 13
Galleon Pharmaceuticals 14
Rottapharm SpA 15
SK Biopharmaceuticals Co., Ltd. 16
Sleep Apnea - Therapeutics Assessment 17
Assessment by Monotherapy Products 17
Assessment by Target 18
Assessment by Mechanism of Action 20
Assessment by Route of Administration 22
Assessment by Molecule Type 24
Drug Profiles 25
CX-1739 - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
CX-2007 - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
CX-2076 - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
dexloxiglumide - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
doxapram hydrochloride - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
dronabinol - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
GAL-021 - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
GAL-160 - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
GAL-160 Backups - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
itriglumide - Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
SKL-N05 - Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Sleep Apnea - Recent Pipeline Updates 38
Sleep Apnea - Dormant Projects 42
Sleep Apnea - Discontinued Products 43
Sleep Apnea - Product Development Milestones 44
Featured News & Press Releases 44
Sep 02, 2014: Galleon Pharmaceuticals Announces Publication of Proof-of-Concept Clinical Studies for GAL-021, Projected Use for the Emerging Perioperative Sleep Apnea Epidemic 44
Jan 06, 2014: Galleon Scientists Win Prestigious Research Awards for First-in-Class Treatment of Emerging Perioperative Sleep Apnea Epidemic 45
Apr 11, 2013: Galleon Pharma's GAL-021 Demonstrates Positive Results In Clinical Proof-of-Concept Study 45
Mar 13, 2012: Cortex Reports Issuance Of Patents For Next Generation Of Ampakine Compounds 46
Mar 13, 2012: Cortex Obtains Patents For Next Generation Of Ampakine Compounds 47
Apr 26, 2011: Cortex Receives US Patent For Lead AMPAKINE Molecule CX1739 47
Feb 02, 2011: Cortex's Ampakine CX1739 Improves Respiratory Parameters In Obstructive Sleep Apnea Patients 48
Appendix 50
Methodology 50
Coverage 50
Secondary Research 50
Primary Research 50
Expert Panel Validation 50
Contact Us 50
Disclaimer 51

List of Tables
Number of Products under Development for Sleep Apnea, H1 2015 7
Number of Products under Development for Sleep Apnea - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Clinical Stage Development, H1 2015 10
Comparative Analysis by Early Stage Development, H1 2015 11
Products under Development by Companies, H1 2015 12
Sleep Apnea - Pipeline by Cortex Pharmaceuticals, Inc., H1 2015 13
Sleep Apnea - Pipeline by Galleon Pharmaceuticals, H1 2015 14
Sleep Apnea - Pipeline by Rottapharm SpA, H1 2015 15
Sleep Apnea - Pipeline by SK Biopharmaceuticals Co., Ltd., H1 2015 16
Assessment by Monotherapy Products, H1 2015 17
Number of Products by Stage and Target, H1 2015 19
Number of Products by Stage and Mechanism of Action, H1 2015 21
Number of Products by Stage and Route of Administration, H1 2015 23
Number of Products by Stage and Molecule Type, H1 2015 24
Sleep Apnea Therapeutics - Recent Pipeline Updates, H1 2015 38
Sleep Apnea - Dormant Projects, H1 2015 42
Sleep Apnea - Discontinued Products, H1 2015 43